F. Chun

Potential of pre-interventional magnetic resonance angiography for optimization of workflow and clinical outcome of prostatic arterial embolization.

T. Vogl, C. Booz, N. Nour-Eldin, 2022, European journal of radiology.

Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer

P. Bankhead, Bernd Bodenmiller, T. Hermanns, 2021, bioRxiv.

Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial.

I. König, A. Muacevic, C. Rödel, 2023, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau)

R. Grobholz, M. Kwiatkowski, F. Recker, 2015, World Journal of Urology.

PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.

T. Steuber, A. Semjonow, J. Hanske, 2021, European urology oncology.

Prostate cancer characteristics and cancer-specific mortality of Native American patients

F. Saad, P. Karakiewicz, M. Deuker, 2019, Prostate Cancer and Prostatic Diseases.